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ALS—dying forward, backward or outward? 
 
Heiko Braak and colleagues (Amyotrophic lateral sclerosis—a model of corticofugal axonal spread. 
Nature Rev. Neurol. 9, 708–714; 2013)1 present impressively detailed evidence in support of 
corticofugal spread – also known as the ‘dying-forward’ model of neurodegeneration, first proposed 
by Eisen and Weber2 - in amyotrophic lateral sclerosis (ALS). Here, I propose a refinement that 
integrates both the ‘dying-forward’ and ‘dying-back’3 models: the corticofugal synaptopathy, or, 
‘dying-outward’ hypothesis. 
In any model of ALS, a number of fundamental features have to be reconciled: First, degenerative 
changes occur primarily in anterior horn cells and brainstem motoneurons that receive monosynaptic 
connections from motor cortex,4 and in the corticospinal tract neurons within primary motor cortex. 
Second, in some variants of ALS, the disease only affects the corticospinal tract neurons5, whereas in 
other variants, it only affects anterior horn cells, or affects corticospinal tract neurons only very late in 
the disease6. Third, ALS progresses contiguously between spinal, brainstem and cortical regions, in 
what has been termed a ‘prion-like’ pattern7. Fourth, cortical areas involved late in the disease are 
linked via long-range synaptic connections1. Last, humans are the only species affected by sporadic 
ALS and only nonhuman primate models of ALS have recapitulated features of the disease observed 
in humans8. 
An important component of the corticofugal model1 is the axonal transport hypothesis, which 
identifies the importance of long-range axonal connections in disease propagation, but overlooks the 
synapse—the very reason for the existence of such connections. Not only does the developing 
synapse, or growth cone, function independently9 but there is also evidence that synaptic autonomy 
continues into adulthood10. For example, synaptic prion-like proteins maintain activity-dependent 
changes in synaptic efficacy independently of nuclear transcription within neuronal somata. 
Furthermore, mitochondria, essential for calcium buffering and energy, are maintained autonomously 
within the presynaptic and postsynaptic compartments11. Such autonomy permits efficient long-
distance neuronal communication, but there is a trade-off: the lysosomal housekeeping processes 
responsible for recycling biomolecules, organelles and cellular debris located within the distant soma 
function less efficiently. Consequently, abnormal conformational changes in prion-like proteins can 
replicate and propagate without control and dysfunctional mitochondria accumulate10, 11. The longer 
the axon and the larger the synapse, the more likely this autonomous process is to malfunction, hence 
the susceptibility of the monosynaptic cortico-motoneuronal synapse at the onset of ALS in man.  
The cortico-motoneuronal synapse is a feature that distinguishes primates from other mammalian 
species, and the number of corticomotoneuronal synapses and length of  axons in the corticospinal 
tract that distinguish humans from nonhuman primates12. Mutations in mitochondrial DNA have been 
implicated in motor neuron diseases13 and ALS14, and there is increasing evidence that the interaction 
between pathological synaptic mitochondria and synaptic prion proteins leads to neurodegeneration11. 
The cortico-motoneuronal synapse, therefore, is not only pivotal as the link between the corticospinal 
tract and anterior horn cells but also; because of its vulnerability, it is an efficient nidus for 
neurodegeneration. Consequently, biomarkers that can detect changes in the integrity of the cortico-
motoneuronal synapse15 should be able to identify the very earliest stages of ALS, enabling early 
disease-modifying therapeutic interventions at a stage when they can make a significant impact on 
survival in this dreadful disease. 
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